Minimally Invasive Surgery for Pancreatic Neuroendocrine Tumors

Minimally invasive surgery for left pancreatic resection in patients with resectable pancreatic neuroendocrine tumors reduces major complications and offers comparable long-term oncologic outcomes. A study comparing minimally invasive and open surgery showed lower rates of major morbidity, postoperative complications, and better outcomes with minimally invasive surgery. This suggests that minimally invasive surgery can be safely recommended for patients with distal pancreatic neuroendocrine tumors.